SCHEMBL6211636

SCHEMBL6211636

Brc1cnc(Nc2ccc3[nH]ccc3c2)nc1NCCc1ccccn1.Brc1cnc(Nc2cccc3[nH]ccc23)nc1NCCc1ccccn1

nearest known ligand 0.44

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ PTK2 Q05397 2/20 0.44
▸ PTK2B Q14289 2/20 0.44
▸ IGF1R P08069 3/20 0.44
▸ EGFR P00533 3/20 0.44
▸ ULK1 O75385 3/20 0.42
▸ PAK4 O96013 4/20 0.41
▸ F2 P00734 1/20 0.40
▸ SYK P43405 1/20 0.38
▸ MARK3 P27448 2/20 0.38
▸ MARK4 Q96L34 2/20 0.38
▸ AURKA O14965 1/20 0.38
▸ TBK1 Q9UHD2 1/20 0.38
▸ STK17A Q9UEE5 1/20 0.38
▸ CDK1 P06493 1/20 0.38
▸ FGFR1 P11362 1/20 0.38
▸ KDR P35968 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6209954 0.92 IGF1R (0.51) PTK2PTK2BIGF1REGFRULK1
SCHEMBL6209471 0.92 IGF1R (0.47) PTK2PTK2BIGF1REGFRF2
SCHEMBL6255244 0.86 PTK2 (0.47) PTK2PTK2BIGF1REGFRPAK4
SCHEMBL6212362 0.84 PTK2 (0.53) PTK2PTK2BIGF1REGFRSYK
SCHEMBL6213157 0.83 PTK2 (0.61) PTK2PTK2BIGF1REGFRULK1
SCHEMBL6212411 0.83 PTK2 (0.50) PTK2PTK2BIGF1RSYKCDK1
SCHEMBL6210750 0.81 IGF1R (0.49) PTK2PTK2BIGF1RMARK3MARK4
SCHEMBL6213407 0.80 PTK2 (0.45) PTK2PTK2BIGF1REGFRPAK4
SCHEMBL6213710 0.79 IGF1R (0.49) PTK2PTK2BIGF1RSYKFGFR1
SCHEMBL6210226 0.79 PTK2 (0.61) PTK2PTK2BIGF1REGFRULK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1578732-A2 PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELL GROWTH Pfizer Products Inc. (US) 2005-09-28 — — EP disclosed
WO-2004056786-A2 PYRIMIDINE DERIVATES FOR THE TREATMENT OF ABNORMAL CELL GROWTH PFIZER PRODUCTS INC. (US) 2004-07-08 — — WO disclosed
Send feedback